Skip to main content
Fig. 5 | Malaria Journal

Fig. 5

From: A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

Fig. 5

Kaplan–Meier cumulative incidence curve for time to a re-emergence, b recrudescence and c re-infection in African patients aged ≤ 5 years (mITT Set). Kaplan–Meier estimates below each graph are estimates of the cumulative incidence rates. All doses of artefenomel and ferroquine are expressed as adult-equivalent doses. Patients with no event were censored at the time of study completion, premature study discontinuation, including switch to established anti-malarial treatment or start of any other treatment with anti-malarial activity, whichever was earliest

Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us